$1.30
3.17% yesterday
Nasdaq, Aug 12, 10:00 pm CET
ISIN
US4626841013
Symbol
IRIX

IRIDEX Corporation Stock price

$1.30
+0.28 27.45% 1M
-0.20 13.33% 6M
-0.38 22.62% YTD
-0.66 33.67% 1Y
-2.07 61.42% 3Y
-1.07 45.15% 5Y
-5.43 80.68% 10Y
-6.00 82.19% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+0.04 3.17%

Key metrics

Basic
Market capitalization
$21.2m
Enterprise Value
$17.6m
Net debt
positive
Cash
$7.2m
Shares outstanding
16.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.4 | 0.4
EV/Sales
0.4 | 0.3
EV/FCF
negative
P/B
3.1
Financial Health
Equity Ratio
7.2%
Return on Equity
-424.9%
ROCE
-27.0%
ROIC
-32.5%
Debt/Equity
0.5
Financials (TTM | estimate)
Revenue
$48.8m | $53.3m
EBITDA
$-4.7m | $-2.6m
EBIT
$-5.2m | $-5.0m
Net Income
$-7.1m | $-4.6m
Free Cash Flow
$-6.8m
Growth (TTM | estimate)
Revenue
-2.3% | 9.6%
EBITDA
52.4% | 67.0%
EBIT
52.4% | 39.8%
Net Income
34.9% | 48.2%
Free Cash Flow
-22.7%
Margin (TTM | estimate)
Gross
41.2%
EBITDA
-9.6% | -4.8%
EBIT
-10.7%
Net
-14.6% | -8.7%
Free Cash Flow
-14.0%
More
EPS
$-0.4
FCF per Share
$-0.4
Short interest
2.3%
Employees
93
Rev per Employee
$520.0k
Show more

Is IRIDEX Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

IRIDEX Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a IRIDEX Corporation forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a IRIDEX Corporation forecast:

Hold
50%
Sell
50%

Financial data from IRIDEX Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
49 49
2% 2%
100%
- Direct Costs 29 29
3% 3%
59%
20 20
1% 1%
41%
- Selling and Administrative Expenses 21 21
17% 17%
42%
- Research and Development Expense 4.79 4.79
28% 28%
10%
-4.67 -4.67
52% 52%
-10%
- Depreciation and Amortization 0.55 0.55
51% 51%
1%
EBIT (Operating Income) EBIT -5.22 -5.22
52% 52%
-11%
Net Profit -7.13 -7.13
35% 35%
-15%

In millions USD.

Don't miss a Thing! We will send you all news about IRIDEX Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

IRIDEX Corporation Stock News

Neutral
Seeking Alpha
about 2 hours ago
IRIDEX Corporation (NASDAQ:IRIX ) Q2 2025 Earnings Conference Call August 12, 2025 5:00 PM ET Company Participants Patrick Mercer - CEO, President & Director Romeo R. Dizon - Chief Financial Officer Conference Call Participants Philip Taylor - Gilmartin Group LLC Operator Thank you for standing by.
Neutral
GlobeNewsWire
about 7 hours ago
MOUNTAIN VIEW, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results for the second quarter ended June 28, 2025.
Neutral
GlobeNewsWire
about 2 months ago
MOUNTAIN VIEW, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, announced today that the first patient has been successfully enrolled in the independent, investigator-led DAME Trial to evaluate the cl...
More IRIDEX Corporation News

Company Profile

IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.

Head office United States
CEO Patrick Mercer
Employees 93
Founded 1989
Website www.iridex.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today